Articles and Blogs

The health care transactional landscape may have been quieter than anticipated at the beginning of 2025, with providers experiencing financial strains, but the year finished out with a high level of activity, marked by opportunistic growth strategies. Transactions will continue to be anything but “cookie-cutter.” In this article, we highlight eight M&A trends demonstrating... READ MORE

New York’s regulatory oversight of health care transactions is evolving rapidly. The Disclosure of Material Transactions Law (Article 45-A of the Public Health Law), which took effect August 1, 2023, introduced new pre-closing reporting obligations for health care entities. Now, Governor Kathy Hochul’s proposed amendments—introduced in her January 21, 2025 executive budget—aim to significantly... READ MORE

On February 7, 2025, legislators introduced Washington State House Bill 1881 and its companion bill, Senate Bill 5704 (collectively, the “Bills”), to enhance oversight and regulation of material changes within the state’s health care marketplace. The Bills’ primary stated objectives are to ensure that health care transactions do not adversely affect the accessibility, affordability... READ MORE

On February 12, 2025, the Texas House of Representatives (“House”) introduced House Bill 2747 (“H.B. 2747”), which would require entities to report certain health care transactions to the Texas Attorney General (“AG”). If passed, H.B. 2747 would go into effect on September 1, 2025, adding Texas to the growing list of states exercising increased... READ MORE

In 2024, the health care M&A marketplace remained dynamic with established industry players and disruptive new entrants engaging in a variety of transactions despite continuing inflation, fluctuating interest rates and a contentious presidential election creating significant uncertainty for providers and investors alike. As Hall Render’s Health Transactions team reflects on 2024 and looks ahead... READ MORE